Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 11,660,340 | 11,876,140 | 13,232,590 | 11,431,640 | 11,281,480 |
| Cost of Goods | 3,304,999 | 3,879,883 | 3,858,583 | 3,458,650 | 3,231,936 |
| Gross Profit | 8,355,346 | 7,996,258 | 9,374,011 | 7,972,986 | 8,049,541 |
| Operating Expenses | 5,680,357 | 5,910,148 | 5,065,792 | 6,340,089 | 5,359,441 |
| Operating Income | 2,675,986 | 2,086,994 | 4,308,802 | 1,633,548 | 2,691,035 |
| Interest Expense | 180,331 | 153,605 | 103,742 | 107,484 | 98,754 |
| Other Income | 153,497 | 2,311,741 | -1,505,764 | -54,275 | 43,767 |
| Pre-tax Income | 2,649,152 | 4,245,131 | 2,699,296 | 1,471,789 | 2,636,048 |
| Income Tax | 492,691 | 962,159 | 605,327 | 173,465 | 372,570 |
| Net Income Continuous | 2,156,461 | 3,282,972 | 2,093,969 | 1,298,324 | 2,263,478 |
| Minority Interests | 15,028 | 59,169 | 3,022 | 47,889 | 8,978 |
| Net Income | $2,141,433 | $3,223,803 | $2,090,947 | $1,250,435 | $2,254,500 |
| EPS Basic Total Ops | 0.86 | 1.28 | 0.84 | 0.50 | 0.90 |
| EPS Basic Continuous Ops | 0.86 | 1.31 | 0.84 | 0.52 | 0.91 |
| EPS Diluted Total Ops | 0.86 | 1.27 | 0.84 | 0.50 | 0.90 |
| EPS Diluted Continuous Ops | 0.86 | 1.30 | 0.84 | 0.52 | 0.91 |
| EPS Diluted Before Non-Recurring Items | 1.16 | 0.87 | 1.45 | N/A | N/A |
| EBITDA(a) | $2,675,986 | $2,086,996 | $4,308,802 | $1,633,548 | $2,691,035 |